Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stacey L House

Showing results (1-10 of 89) with videos related to

Pageof 9
Sort By:
Applied Clinical Informatics|April 7, 2021
Shared-Task Worklists Improve Clinical Trial Recruitment Workflow in an Academic Emergency DepartmentKevin S Naceanceno, Stacey L House, Phillip V Asaro
Frontiers in Cardiovascular Medicine|October 10, 2022
Fibroblast growth factor receptor signaling in cardiomyocytes is protective in the acute phase following ischemia-reperfusion injuryDzmitry Matsiukevich, Stacey L House, Carla Weinheimer, et al.
American Journal of Physiology. Heart and Circulatory Physiology|July 26, 2005
Cardioprotection induced by cardiac-specific overexpression of fibroblast growth factor-2 is mediated by the MAPK cascadeStacey L House, Kevin Branch, Gilbert Newman, et al.
American Journal of Physiology. Heart and Circulatory Physiology|March 6, 2007
The protein kinase C pathway mediates cardioprotection induced by cardiac-specific overexpression of fibroblast growth factor-2Stacey L House, Susan J Melhorn, Gilbert Newman, et al.
Physiological Reports|January 29, 2015
Fibroblast growth factor 2 is an essential cardioprotective factor in a closed-chest model of cardiac ischemia-reperfusion injuryStacey L House, Joy Wang, Angela M Castro, et al.
Chest|August 17, 2013
Albuterol administration is commonly associated with increases in serum lactate in patients with asthma treated for acute exacerbation of asthmaLawrence M Lewis, Ian Ferguson, Stacey L House, et al.
Circulation|December 6, 2003
Cardiac-specific overexpression of fibroblast growth factor-2 protects against myocardial dysfunction and infarction in a murine model of low-flow ischemiaStacey L House, Craig Bolte, Ming Zhou, et al.
Respiratory Medicine|August 5, 2014
Repeated dyspnea score and percent FEV1 are modest predictors of hospitalization/relapse in patients with acute asthma exacerbationJohn E Schneider, Lawrence M Lewis, Ian Ferguson, et al.
American Journal of Physiology. Heart and Circulatory Physiology|January 10, 2016
Endothelial fibroblast growth factor receptor signaling is required for vascular remodeling following cardiac ischemia-reperfusion injuryStacey L House, Angela M Castro, Traian S Lupu, et al.
Molecular and Cellular Pharmacology|January 29, 2011
Fibroblast Growth Factor 2 Mediates Isoproterenol-induced Cardiac Hypertrophy through Activation of the Extracellular Regulated KinaseStacey L House, Brian E House, Betty Glascock, et al.
Pageof 9

Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
Applied Clinical Informatics|April 7, 2021
Shared-Task Worklists Improve Clinical Trial Recruitment Workflow in an Academic Emergency DepartmentKevin S Naceanceno, Stacey L House, Phillip V Asaro
Frontiers in Cardiovascular Medicine|October 10, 2022
Fibroblast growth factor receptor signaling in cardiomyocytes is protective in the acute phase following ischemia-reperfusion injuryDzmitry Matsiukevich, Stacey L House, Carla Weinheimer, et al.
American Journal of Physiology. Heart and Circulatory Physiology|July 26, 2005
Cardioprotection induced by cardiac-specific overexpression of fibroblast growth factor-2 is mediated by the MAPK cascadeStacey L House, Kevin Branch, Gilbert Newman, et al.
American Journal of Physiology. Heart and Circulatory Physiology|March 6, 2007
The protein kinase C pathway mediates cardioprotection induced by cardiac-specific overexpression of fibroblast growth factor-2Stacey L House, Susan J Melhorn, Gilbert Newman, et al.
Physiological Reports|January 29, 2015
Fibroblast growth factor 2 is an essential cardioprotective factor in a closed-chest model of cardiac ischemia-reperfusion injuryStacey L House, Joy Wang, Angela M Castro, et al.
Chest|August 17, 2013
Albuterol administration is commonly associated with increases in serum lactate in patients with asthma treated for acute exacerbation of asthmaLawrence M Lewis, Ian Ferguson, Stacey L House, et al.
Circulation|December 6, 2003
Cardiac-specific overexpression of fibroblast growth factor-2 protects against myocardial dysfunction and infarction in a murine model of low-flow ischemiaStacey L House, Craig Bolte, Ming Zhou, et al.
Respiratory Medicine|August 5, 2014
Repeated dyspnea score and percent FEV1 are modest predictors of hospitalization/relapse in patients with acute asthma exacerbationJohn E Schneider, Lawrence M Lewis, Ian Ferguson, et al.
American Journal of Physiology. Heart and Circulatory Physiology|January 10, 2016
Endothelial fibroblast growth factor receptor signaling is required for vascular remodeling following cardiac ischemia-reperfusion injuryStacey L House, Angela M Castro, Traian S Lupu, et al.
Molecular and Cellular Pharmacology|January 29, 2011
Fibroblast Growth Factor 2 Mediates Isoproterenol-induced Cardiac Hypertrophy through Activation of the Extracellular Regulated KinaseStacey L House, Brian E House, Betty Glascock, et al.
Pageof 9